ETHRIS
ETHRIS develops mRNA therapeutics with a focus on respiratory diseases and vaccines. ETHRIS possesses an enabling LNP delivery and mRNA modification platform for transcript Therapies. SNIM®RNAis a first-in-class biopharmaceutical which provide a compelling alternative for recombinant protein or gene therapies. SNIM®RNAs encode therapeutic proteins to be produced in the patient‘s body and overcome short duration effects of recombinant proteins. SNIM®RNA Transcript Therapy is a new option for a broad variety of diseases, either acquired or genetically predetermined, lifestyle- or age-related, rare or frequent.
ETHRIS
Industry:
Bioinformatics Biopharma Biotechnology Genetics Pharmaceutical
Founded:
2009-01-01
Address:
Planegg, Bayern, Germany
Country:
Germany
Website Url:
http://www.ethris.com
Total Employee:
101+
Status:
Active
Contact:
+4908989557880
Email Addresses:
[email protected]
Total Funding:
74.42 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Nginx Euro Microsoft Exchange Online Office 365 Mail IPv6
Similar Organizations
Bicycle Therapeutics
Bicycle Therapeutics is developing a technology for the creation of new generation biotherapeutics.
Current Employees Featured
Founder
Investors List
Laureus Capital
Laureus Capital investment in Series B - ETHRIS
Bavarian Ministry of Economics / Bayerisches Wirtschaftsministerium
Bavarian Ministry of Economics / Bayerisches Wirtschaftsministerium investment in Grant - ETHRIS
AstraZeneca
AstraZeneca investment in Corporate Round - ETHRIS
OrbiMed
OrbiMed investment in Series A - ETHRIS
HS LifeSciences
HS LifeSciences investment in Series A - ETHRIS
Official Site Inspections
http://www.ethris.com Semrush global rank: 7.11 M Semrush visits lastest month: 588
- Host name: vwp4608.webpack.hosteurope.de
- IP address: 83.169.26.88
- Location: Germany
- Latitude: 51.4476
- Longitude: 7.0122
- Timezone: Europe/Berlin
